← back to search

Silke Kern

Sahlgrenska University Hospital ·
Area of research
Psychiatry and Mental health · Physiology
Research interest
Research interests include Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Nutritional Studies and Diet, and Advanced Neuroimaging Techniques and Applications.
h-index
38
citations
7,719
works
250
NIH funding
primary concept
email

Recent publications

Plasma phospho-tau217 for Alzheimer’s disease diagnosis in primary and secondary care using a fully automated platform
Nature Medicine 2025cited by 113position: middledoi
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sex
Nature Neuroscience 2025cited by 30position: middledoi
Depressive Symptoms and Amyloid Pathology
JAMA Psychiatry 2025cited by 19position: middledoi
Evaluation of two plasma‐based proteotyping assays against <i>APOE</i> ε4 genotyping in a memory clinic setting: The Gothenburg H70 Clinical Studies
Alzheimer s & Dementia 2025cited by 9position: lastdoi
Profiling brain morphology for autism spectrum disorder with two cross-culture large-scale consortia
Communications Biology 2025cited by 3position: middledoi
Risk and protective factors associated with brain grey matter patterns in a population-based cohort of cognitively unimpaired 70 years old
BMC Medicine 2025cited by 1position: middledoi
Cerebrovascular and Alzheimer’s disease biomarkers in dementia with Lewy bodies and other dementias
Brain Communications 2024cited by 19position: middledoi
Biological brain age and resilience in cognitively unimpaired 70‐year‐old individuals
Alzheimer s & Dementia 2024cited by 19position: middledoi
Mass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologies
Nature Aging 2023cited by 114position: middledoi
Association of Chronic Kidney Disease With Plasma NfL and Other Biomarkers of Neurodegeneration
Neurology 2023cited by 71position: lastdoi
Multiancestry analysis of the HLA locus in Alzheimer’s and Parkinson’s diseases uncovers a shared adaptive immune response mediated by <i>HLA-DRB1*04</i> subtypes
Proceedings of the National Academy of Sciences 2023cited by 47position: middledoi
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum
JAMA Neurology 2022cited by 280position: middledoi
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Acta Neuropathologica 2022cited by 135position: middledoi
Plasma and CSF NfL are differentially associated with biomarker evidence of neurodegeneration in a community‐based sample of 70‐year‐olds
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2022cited by 35position: lastdoi
Publisher Correction: Brain charts for the human lifespan
Nature 2022cited by 14position: middledoi
Protective association of <i>HLA‐DRB1</i>*04 subtypes in neurodegenerative diseases implicates acetylated tau PHF6 sequences
Alzheimer s & Dementia 2022cited by 2position: middledoi
A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease
Nature Genetics 2021cited by 1,074position: middledoi
Metabolic Syndrome Is Associated With Poor Cognition: A Population-Based Study of 70-Year-Old Adults Without Dementia
The Journals of Gerontology Series A 2021cited by 46position: middledoi
Atrial Fibrillation, Stroke, and Silent Cerebrovascular Disease
Neurology 2021cited by 44position: middledoi
Deep learning from MRI-derived labels enables automatic brain tissue classification on human brain CT
NeuroImage 2021cited by 38position: middledoi
Twenty-seven-year time trends in dementia incidence in Europe and the United States
Neurology 2020cited by 472position: middledoi
Predicting Fazekas scores from automatic segmentations of white matter signal abnormalities
Aging 2020cited by 69position: middledoi
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and <i>APOE</i> genotype
Alzheimer s & Dementia 2019cited by 559position: middledoi
White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities
Alzheimer s & Dementia Translational Research & Clinical Interventions 2019cited by 438position: middledoi
The Gothenburg H70 Birth cohort study 2014–16: design, methods and study population
European Journal of Epidemiology 2018cited by 165position: middledoi
Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
Translational Psychiatry 2017cited by 75position: middledoi
Trends in the incidence of dementia: design and methods in the Alzheimer Cohorts Consortium
European Journal of Epidemiology 2017cited by 26position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ingmar Skoog · Skåne University Hospital11 papers (2017–2025)Anna Zettergren · Karolinska Institutet8 papers (2017–2024)Eric Westman · Wellcome Centre for Human Neuroimaging7 papers (2020–2024)Sara Shams · Karolinska University Hospital6 papers (2020–2025)Kaj Blennow · First Affiliated Hospital of Anhui Medical University6 papers (2017–2025)Henrik Zetterberg · Indian Institute of Science Bangalore5 papers (2017–2025)Lina Rydén · Karolinska Institutet4 papers (2021–2025)Nicholas J. Ashton · Alzheimer's Association4 papers (2022–2025)Lars‐Olof Wahlund · Karolinska Institutet3 papers (2020–2021)Alejandra Machado · Karolinska Institutet3 papers (2020–2023) · 3 papers (2022–2025)Anna Marseglia · Karolinska Institutet3 papers (2021–2025)Michael Schöll · Wallenberg Wood Science Center3 papers (2021–2023) · 2 papers (2021–2024)Therese Rydberg Sterner · Malmö University2 papers (2021–2024)Joana B. Pereira · Karolinska Institutet2 papers (2021–2021)Rosaleena Mohanty · Karolinska Institutet2 papers (2024–2025) · 2 papers (2022–2023)Simona Sacuiu · Karolinska University Hospital2 papers (2020–2021)Olof Lindberg · Karolinska Institutet2 papers (2024–2025)